Table I. Summary of GT experiments targeting ALS locus.
| TF First | TF Second Transformed Callia | BSR Calli | W548L, S627I Mutations in Endogenous ALS Gene | Ratio of Calli with W548L and S627I (%)b | Recovery of Regenerated Plantsc | ||||
|---|---|---|---|---|---|---|---|---|---|
| W548L and S627I | W548L | None | |||||||
| Homo | Hetero | Homo | Hetero | ||||||
| Exp. 1 | |||||||||
| pCAMBIA-sGFP Mix | 2753 (13.7g) | 3 | 0 | 0 | 0 | 2 | 1 | 0 | 0 |
| pZH_MMCas9 Mix | 3994 (15.5g) | 3 | 0 | 0 | 0 | 2 | 1 | 0 | 0 |
| Exp. 2 | |||||||||
| pCAMBIA-sGFP no. 1 | 674 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| pCAMBIA-sGFP no. 10 | 665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| pCAMBIA-sGFP no. 12 | 589 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| pZH_MMCas9 no. 1 | 821 | 4 | 0 | 0 | 0 | 2 | 2 | 0 | 0 |
| pZH_MMCas9 no. 2 | 881 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| pZH_MMCas9 no. 3 | 830 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Exp. 3 | |||||||||
| pZH_MMCas9 Mix | 872 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| pZH_gLig4-1_MMCas9 Mix | 985 | 19 | 0 | 8 | 0 | 7 | 4 | 0.812 | 4 |
| pZH_gLig4-2_MMCas9 Mix | 829 | 12 | 1 | 3 | 1 | 4 | 3 | 0.483 | 3 |
| Exp. 4 | |||||||||
| pZH_MMCas9 no. 2 | 1109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| pZH_MMCas9 no. 3 | 929 | 7 | 0 | 3 | 0 | 3 | 1 | 0.323 | 3 |
| pZH_gLig4-1_MMCas9 no. 1 | 729 | 9 | 0 | 3 | 0 | 3 | 3 | 0.412 | 2 |
| pZH_gLig4-1_MMCas9 no. 2 | 1100 | 24 | 3 | 8 | 1 | 8 | 4 | 1.000 | 7 |
| pZH_gLig4-2_MMCas9 no. 5 | 682 | 5 | 0 | 1 | 0 | 2 | 2 | 0.147 | 1 |
| pZH_gLig4-2_MMCas9 no. 10 | 1003 | 10 | 0 | 4 | 0 | 5 | 1 | 0.399 | 2 |
| Exp. 5 | |||||||||
| T1 (lig4, +1(A) homo; pZH_gLig4-1_MMCas9, segregated out) | 877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |